Drug Safety Matters
A podcast by Uppsala Monitoring Centre
42 Episodes
-
#27 When drugs damage the liver – Rita Baião
Published: 2/1/2024 -
#26 What's trending in pharmacovigilance? – Angela Caro
Published: 12/20/2023 -
#25 A week in the name of medicines safety – part 2
Published: 11/13/2023 -
#24 A week in the name of medicines safety – part 1
Published: 11/2/2023 -
Uppsala Reports Long Reads – The colour of signals
Published: 9/29/2023 -
Uppsala Reports Long Reads – Empowering patients as partners
Published: 9/5/2023 -
#23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić
Published: 6/27/2023 -
#22 Reforming pharmacovigilance education – Michael Reumerman
Published: 5/8/2023 -
#21 Unlocking the power of real-world data – Patrick Ryan
Published: 3/30/2023 -
#20 The evidence for signals – Daniele Sartori
Published: 2/23/2023 -
Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era
Published: 1/26/2023 -
#19 Lessons in pandemic pharmacovigilance – Elena Rocca
Published: 12/15/2022 -
#18 The IDMP standards explained – Malin Fladvad & Olle Lagerlund
Published: 9/29/2022 -
#17 Why we need vaccine surveillance systems – Madhava Balakrishnan
Published: 8/24/2022 -
#16 How drug safety can help fight resistant bugs – Jean Marie Vianney Habarugira & Albert Figueras
Published: 6/30/2022 -
#15 Safety of HIV medications – Henry Zakumumpa
Published: 4/29/2022 -
#14 Advancing pharmacovigilance in Africa – Eleni Aklillu & Abbie Barry
Published: 3/24/2022 -
#13 How to talk about risks – Alexandra Freeman
Published: 2/24/2022 -
Uppsala Reports Long Reads – Safety issues faced by refugee communities
Published: 1/27/2022 -
#12 Improving signal detection with vigiGroup – Jim Barrett & Joe Mitchell
Published: 12/16/2021
Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring.